Is Michael Burry early again, or is Applied Materials flashing the kind of warning investors ignore at market peaks?
Why Is Applied Materials Short So Controversial?
Michael Burry’s newly disclosed Applied Materials Short arrives amid unprecedented momentum: the stock hit a record high on June 30, outperforming peers like NVIDIA and Tesla on the back of surging AI-driven wafer fab equipment demand. Burry sold short at $729.40—just 4% above current levels—citing extreme technical overextension: the Philadelphia Semiconductor Index (SOXX) now trades 65% above its 200-day moving average, a threshold last seen during the 2000 Dotcom peak. His thesis isn’t about AMAT’s fundamentals—it’s about market structure. When the SOXX hits such extremes, history shows median drawdowns exceed 30%. For S&P 500 investors holding semiconductor-heavy ETFs or AI-focused growth portfolios, this Applied Materials Short is a stress test on valuation discipline.
What Do Analysts Say About Applied Materials, Inc.?
Contrast Burry’s bearish signal with overwhelming analyst enthusiasm. Cantor Fitzgerald’s C.J. Muse raised the price target for Applied Materials, Inc. from $650 to $850 while maintaining an Overweight rating. KeyBanc’s Steve Barger lifted his target to $750 and reiterated a Buy, citing memory-capacity expansion by Samsung and SK Hynix as a multi-year catalyst. RBC Capital Markets has not yet weighed in, but Morgan Stanley analysts noted AMAT’s order backlog now exceeds $18 billion—its highest ever—and expects Q3 2026 revenue to grow 22% year-over-year. Yet even bulls concede risk: Stocktwits reports KeyBanc warned that high expectations for semiconductor capex could trigger volatility if guidance misses—even with strong execution.
How Does Applied Materials Compare to Competitors?
While Applied Materials, Inc. surged 54% in June, peers showed divergence. NVIDIA rose 37% over the same period, and ASML gained 28%, but KLA Corp. lagged with just 12%. This suggests investors aren’t betting on the entire semiconductor equipment stack—they’re concentrating on AI-adjacent leaders. AMAT’s strength stems from its dominance in atomic layer deposition (ALD) and etch systems, critical for advanced AI chip packaging. Still, Burry’s inclusion of AMAT alongside Tesla and Caterpillar in his short basket signals a broader skepticism about infrastructure beneficiaries—not just chip designers. That makes this Applied Materials Short less about AMAT alone and more about whether the entire AI capex trade has entered late-cycle euphoria.
What Does This Mean for S&P 500 and NASDAQ Investors?
Applied Materials, Inc. is a top-20 NASDAQ component and a key S&P 500 tech weight. Its 11.59% intraday gain on July 1 pushes its YTD return to over 140%—far outpacing the S&P 500’s 12% and NASDAQ’s 28%. That outperformance has widened valuation gaps: AMAT now trades at 38x forward earnings, nearly double its 10-year median. For investors holding broad-market ETFs or AI-themed mutual funds, Burry’s Applied Materials Short raises a critical question: is this momentum sustainable—or is it pricing in perfection? With the iShares Semiconductor ETF (SOXX) up 62% YTD and trading at 27x forward P/E, the sector’s sensitivity to any slowdown in AI capex announcements could trigger a swift rotation.
Is the Applied Materials Short a Signal or a Sideshow?
The SOXX itself is a pure form of overvaluation in an index—a rarity that’s rarely easy to spot.— Michael Burry
Burry’s position is small relative to his total portfolio—and his track record includes both legendary calls and prolonged losses. But timing matters: he entered the Applied Materials Short just as South Korea’s chipmakers announced $120 billion in new fab investments. Burry called that “the beginning of the end”—not a catalyst. His logic mirrors 2000, when capex peaks preceded sector-wide corrections. For U.S. investors, this isn’t about betting against AMAT’s engineering prowess—it’s about hedging against a potential regime shift in semiconductor capital spending. With Q3 2026 earnings due in August, the next earnings call will test whether AMAT’s guidance can silence skeptics—or validate Burry’s warning.
